MYCN and neuroblastoma: Roughly 25% of most aggressive neuroblastomas are characterized by the amplification/overexpression of the MYCN transcription factor that nowadays is considered one of the most robust prognostic factors for the neuroblastoma unfavorable outcome (Bordow et al., 1998; Cohn et al., 2009).